mutant RAS
KRAS-dependent
treatment of RAS
hyperactive RAS
RAS oncogenes
oncogenic KRAS
chromatin remodeling
active chromatin
effective RAS inhibitors
models of acute KRAS degradation
consequences of acute mutant KRAS degradation
dependent chromatin regulation amenable
Chromatin dependent signal transduction
urgent clinical need of RAS
Chemical probing of transcriptional RAS effectors Targeted therapies
cellular reporters of KRAS
chemical modulation of critical chromatin
transcription regulators
genetic screens
driven tumors
high-throughput phenotypic drug
high-throughput microscopy
emergence of drug resistance
innovative approach of targeted protein degradation
related therapies
genetic perturbations
therapeutic potential
emergence of resistances
Lead molecules
attractive therapeutic interface
understanding of transcriptional control
CeMM-Research Center
Winter laboratory
Molecular Medicine
regulatory dependencies
computational pipelines
Austrian Academy of Sciences
project
point of confluence
multiple
networks
new avenues
pharmacologic disruption of gene
pancreatic cancer
facile readout
underpinning mechanism of action
disease background
deadly cancers
studies
nodes